RT Journal Article
SR Electronic
T1 AN INTERACTIVE COVID-19 MOBILITY IMPACT AND SOCIAL DISTANCING ANALYSIS PLATFORM
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.29.20085472
DO 10.1101/2020.04.29.20085472
A1 Lei Zhang
A1 Sepehr Ghader
A1 Michael L. Pack
A1 Chenfeng Xiong
A1 Aref Darzi
A1 Mofeng Yang
A1 QianQian Sun
A1 AliAkbar Kabiri
A1 Songhua Hu
YR 2020
UL http://medrxiv.org/content/early/2020/05/05/2020.04.29.20085472.abstract
AB The research team has utilized privacy-protected mobile device location data, integrated with COVID-19 case data and census population data, to produce a COVID-19 impact analysis platform that can inform users about the effects of COVID-19 spread and government orders on mobility and social distancing. The platform is being updated daily, to continuously inform decision-makers about the impacts of COVID-19 on their communities using an interactive analytical tool. The research team has processed anonymized mobile device location data to identify trips and produced a set of variables including social distancing index, percentage of people staying at home, visits to work and non-work locations, out-of-town trips, and trip distance. The results are aggregated to county and state levels to protect privacy and scaled to the entire population of each county and state. The research team are making their data and findings, which are updated daily and go back to January 1, 2020, for benchmarking, available to the public in order to help public officials make informed decisions. This paper presents a summary of the platform and describes the methodology used to process data and produce the platform metrics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received partial financial support from the U.S. Department of Transportation’s Bureau of Transportation Statistics and the National Science Foundation’s RAPID Program.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are available at data.covid.umd.edu https://data.covid.umd.edu/